Yu‐zhong Duan

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index868citations40works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(7), Cancer, Hypoxia, and Metabolism(6), Lung Cancer Treatments and Mutations(5), Virus-based gene therapy research(5), Lung Cancer Research Studies(4)

Publications40 total

Interaction between the BDNF rs11030101 genotype and job stress on cognitive empathy
Journal of Affective Disorders·2022· 2 cited
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
Frontiers in Oncology·2021· 6 citedOpen Access
Analysis of Work-related Stress of Soldiers and Its Influencing Factors under Special Military Environment
Journal of psychiatry·2021
Prevention and control of coronavirus disease 2019 in Grade-III Class-A hospitals outside of Wuhan
Chinese Medical Journal·2020Open Access
Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations
The Oncologist·2019· 78 citedOpen Access
Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer.
PubMed·2019· 14 citedOpen Access
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
Experimental and Therapeutic Medicine·2018· 27 citedOpen Access
Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
Oncotarget·2016· 37 citedOpen Access
Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
Radiation Oncology·2016· 28 citedOpen Access
Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
Tumor Biology·2016· 77 citedOpen Access
IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma
Oncology Reports·2015· 14 citedOpen Access
A Study Design: Concurrent EGFR-TKI and Thoracic Radiotherapy as Firstline Treatment of Stage IV NSCLC Patients with EGFR Active Mutations (CERTAIN Study)
Chemotherapy Open access·2015Open Access
竹拱鋼箍Tan繊維組合せノード構造平面内安定耐力試験【JST・京大機械翻訳】
Nongye Gongcheng Xuebao·2015
Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE<sub>2</sub>production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity
BMB Reports·2014· 18 citedOpen Access
Changes in Cox-2 expression in gastric antrum muscle layer, serum somatostatin and vasoactive intestinal peptide levels in simulated weightlessness in rats
Jiefangjun yixue zazhi·2014
Efficacy and Safety of Endostar<sup>®</sup>Combined with Chemotherapy in Patients with Advanced Soft Tissue Sarcomas
Asian Pacific Journal of Cancer Prevention·2013· 12 citedOpen Access
CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls
Molecular Biology Reports·2013· 2 cited
HSP70 expression in pancreas of rats under the condition of simulated weightlessness
Chin J Pancreatol·2013· 1 cited
Efficacy and Safety of Endostar (R) Combined with Chemotherapy in Patients with Advanced Soft Tissue Sarcomas
2013· 2 cited
Design and application of computer-assisted cancer chemotherapy plan and management system
Zhonghua yixue jiaoyu tansuo zazhi·2012
page 1 of 2Next →

Frequent Co-authors

Zhengtang Chen(17), Jianguo Sun(11), Bo Zhu(8), Zhengtang Chen(8), Fanglin Chen(5), Zheng‐huai Cao(5), Xingyun Liao(4), Dezhi Li(4), Jianguo Sun(4), Yanmei Wang(3), Xiewan Chen(3), Yanmei Xu(3), Rongxia Liao(3), Xinxin Wang(3), Jinlian Zhou(3), Heming Yang(3), Yan Cui(3), Wenlei Zhuo(3), Zhixin Wang(3), Dezhi Li(3)